Group 1 - The core point of the article is that Suzhou Yixi Biotechnology Co., Ltd. has recently completed its Series A financing round, raising nearly 200 million RMB, with the investment coming from Huangshan Xin'anjiang [1] - Suzhou Yixi Biotechnology was established in 2019 and is primarily engaged in research and experimental development, with a registered capital of approximately 6.19 million RMB [1] - The company has made one external investment and holds 29 trademark registrations and 35 patents, along with 4 administrative licenses [1] Group 2 - The shareholders of Suzhou Yixi Biotechnology include Liu Zhenyun, Suzhou Yita Enterprise Management Partnership, Vitalbridge YX Limited, Suzhou Zhengxuan Qianzhan Investment Partnership, and Suzhou Hutou Enterprise Management Partnership [1]
苏州一兮生物技术有限公司获“A轮”融资，金额近2亿人民币
Sou Hu Cai Jing·2025-08-21 02:07